VYNE Chart
- 52-Week Range: $0.37 - $4.11
- Market Capitalization: $22.80M
- Short Percentage: 0%
- Target Price: $5.50
- Shares Outstanding: 57.83M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
VYNE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- VYNE Therapeutics to Present at HC Wainwright & Co. Global Investment ConferenceGlobeNewsWire | May 18th
- VYNE Therapeutics Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire | May 12th
- VYNE Hosting Key Opinion Leader Event on Novel InhiBET™ BET Inhibitor PlatformGlobeNewsWire | May 10th
- VYNE Therapeutics Reports Year-End 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire | March 17th
- VYNE Therapeutics to Present at 42nd Annual Cowen Healthcare ConferenceGlobeNewsWire | March 3rd
- VYNE Therapeutics to Participate at the LifeSci Partners 11th Annual Corporate Access EventGlobeNewsWire | January 3rd
Company Info
Website: https://www.vynetherapeutics.com
Address: 520 U.S. Highway 22, Bridgewater, NJ, United States, 08807
Sector: Healthcare
Industry: Biotechnology
Full time employees: 28
Address: 520 U.S. Highway 22, Bridgewater, NJ, United States, 08807
Sector: Healthcare
Industry: Biotechnology
Full time employees: 28
$VYNE just bought a half position.
$VYNE nothing drops
$VYNE Powell save me
$VYNE all’s I know is buy and hold… no expectations
$VYNE glad I didn’t chase this isn’t moving anytime soon with all of those call options here lol
$VYNE let’s ride
$VYNE watch for another rejection up here
$VYNE who else finds themselves here after liquidating their positions for a loss only to bash on how seriously fcked up the stock market is
$VYNE Overpower the algos!
$VYNE not yet time to short